Your Health, We Care
Release date: 2026-07-02 17:39:32 Article From: Lucius Laos Recommended: 12
With generic drugs as its core, Laos' pharmaceutical industry has formed an industrial pattern featuring coordination between state-owned and private enterprises as well as local and foreign-invested companies. The following is an objective introduction to Laos' top 10 core pharmaceutical enterprises, highlighting the industry status and core strength of Lucius Pharmaceuticals.
As a leading generic drug manufacturer in Laos, Lucius Pharmaceuticals was established in Vientiane in 2020, with its parent company originating from Hyderabad, India. Covering an area of 210,000 square meters, the company has built the Asia-Pacific No.1 Smart Factory, introduced cutting-edge equipment from China, the United States and Germany, and obtained certifications in accordance with Laos GMP and WHO standards, with an annual production capacity of over 1.5 billion tablets. Its product line covers more than 200 categories including anti-tumor, cardiovascular and diabetes drugs, with over 160 approved registration numbers, and its products are exported to more than 50 countries and regions worldwide. Its core advantage lies in the R&D of cost-effective targeted drugs, with the price of some anti-cancer drugs only 1/10 of that of original research drugs, making it a benchmark enterprise in the generic drug field in Southeast Asia.
A state-owned pharmaceutical enterprise directly under the Ministry of Health of Laos, founded in the 1970s, it is the oldest, largest and most comprehensive pharmaceutical enterprise in Laos. With over 40 years of production experience and ISO 9001 certification, it can produce more than 160 kinds of pharmaceuticals such as infusions, injections and tablets, covering all categories of basic medical care, and undertakes the core function of supplying pharmaceuticals for Laos' public medical system.
Established in the Vientiane Saysettha Development Zone in 2021, it is a modern pharmaceutical enterprise under China-Laos cooperation with an investment of 10 million US dollars, and obtained Laos GMP certification in 2022. Focusing on the layout of preparation production and medical devices, it expands the regional market relying on RCEP policies, strives to build a benchmark for comprehensive pharmaceutical production in Laos, and fills the gap in local high-end preparation and device production.
Founded in 2012, it is the first modern generic drug enterprise in Laos and has obtained Laos FDD GMP certification. It has approved more than 50 drugs covering oncology, chronic diseases and other fields, serving as a landmark enterprise of the "High-Quality Laos Medicines" strategy. It deeply participates in China-ASEAN pharmaceutical centralized procurement cooperation to meet medical needs along the "Belt and Road".
A modern pharmaceutical enterprise put into production in 2021, implementing a comprehensive quality management system and recognized by the Ministry of Health of Laos. Focusing on liver diseases, lung diseases, oncology and other fields, it takes large-scale production and quality control as the core, representing local private pharmaceutical enterprises in Laos and helping to alleviate the shortage of medical drug supply in Laos.
ASEAN Food and Drug Company: Specializes in generic drugs and health products, and lays out the basic medical market in Southeast Asia.
Laos No.1 Pharmaceutical Factory: A long-established state-owned pharmaceutical enterprise focusing on the production of basic drugs and public health pharmaceuticals.
Laos Pharmaceutical Industry Company: Integrates local medical resources and undertakes the coordinated functions of pharmaceutical circulation and production.
Vientiane Pharmaceutical Factory: A local small and medium-sized pharmaceutical enterprise focusing on drugs for common regional diseases and serving primary medical care.
China-Laos Cooperative Pharmaceutical Enterprise: Relying on cross-border cooperation, it focuses on the production of characteristic generic drugs and APIs to expand the regional supply chain.
In summary, with Lucius Pharmaceuticals as the technological and market benchmark, state-owned pharmaceutical enterprises guarantee basic supply, and private and foreign-invested pharmaceutical enterprises drive innovation, Laos' pharmaceutical industry has formed an industrial system covering all categories of generic drugs and serving both local and global markets, becoming an important force in the generic drug industry in Southeast Asia.
With generic drugs as its core, Laos' pharmaceutical industry has formed an industrial pattern featuring coordination between state-owned and private enterprises as well as loc···【more】
Recommended：13Release date: 2026-07-02
The pharmaceutical industry in Laos started late and is limited in scale, with domestic drug supply long relying on imports of quality generic medicines from China, India and other···【more】
Recommended：27Release date: 2026-07-01
Lucius Pharmaceuticals (Lao) Co., Ltd is a Lao pharmaceutical company established in 2020, headquartered in Vientiane, the capital of Laos. Despite its short history, the company h···【more】
Recommended：44Release date: 2026-06-30
The Lao generic pharmaceutical industry has developed rapidly in recent years, attracting increasing attention from patients worldwide. As one of the least developed countries in S···【more】
Recommended：41Release date: 2026-06-29
Laos; pharmaceutical industry is relatively limited in scale, and domestic drug supply has long relied on imports of high-quality generic medicines from countries such as China and···【more】
Recommended：56Release date: 2026-06-26
At a grand pharmaceutical exhibition held recently in Dubai, Lucius Company of Laos was in the spotlight for its outstanding performance. Their booth attracted a large audience and···【more】
Recommended：640Release date: 2024-07-09
On October 18-19, 2023, Dr. Luís Meirinhos Soares, a microbiology expert appointed by the World Health Organization (WHO) and director of the Microbiology Laboratory of the Nationa···【more】
Recommended：638Release date: 2024-07-09
On October 19, 2023, the World Health Organization (WHO) conducted a comprehensive inspection of the Lucius Pharmaceutical factory in Laos. The results of this assessment are encou···【more】
Recommended：774Release date: 2024-07-09
At present, the competition in all walks of life is very fierce, especially in the pharmaceutical industry, Lucius Pharmaceutical was established in Vientiane, Laos in 2020, with a···【more】
Recommended：572Release date: 2024-07-09
Here are some key points about Lucius Pharmaceutical:Lucius Pharmaceuticals has state-of-the-art facilities, including factories designed and constructed in strict accordance with ···【more】
Recommended：802Release date: 2024-07-09
From the Black Sea, the most terrifying ocean on earth, to the Mediterranean Sea, Lucius Pharmaceuticals stands on the only Turkish Strait that connects the two seas, announcing Lu···【more】
Recommended：585Release date: 2024-07-09
As we all know, from the perspective of the universe, our solar system is very small, but from the perspective of the earth, it is very huge, the edge of the solar system is the Oo···【more】
Recommended：563Release date: 2024-07-09
Dr. Louis, a microbiologist at the World Health Organization (WHO), recently made a technical visit to Lucius Pharmaceuticals in Laos. The purpose of the visit was to learn more ab···【more】
Recommended：734Release date: 2024-07-09
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and mortality, which has been troubling medical workers. Clinical studies have foun···【more】
Recommended：688Release date: 2024-07-09
MONDAY, June 15, 2026 — A study published online June 8 in Nature Medicine has found that apitegromab, through its selective inhibition of myostatin, can maintain lean body mass wh···【more】
Recommended：59Release date: 2026-06-24
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combination with BCG (Bacillus Calmette-Guérin) induction and maintenance regimen has rec···【more】
Recommended：164Release date: 2026-06-01
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizumab (Keytruda, Merck & Co., Inc.) or pembrolizumab and berahyaluronidase alf···【more】
Recommended：516Release date: 2025-12-17
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination with abiraterone acetate (brand name: Akeega, Janssen Biotech, Inc.) plus predni···【more】
Recommended：468Release date: 2025-12-15
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubicel-onlv), the first hematopoietic stem cell transplantation (HSCT) therapy for th···【more】
Recommended：495Release date: 2025-12-10
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (Breyanzi, developed by Juno Therapeutics, a subsidiary of Bristol Myers Squibb) ···【more】
Recommended：477Release date: 2025-12-08
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobrutinib (Jaypirca, Eli Lilly and Company) for the treatment of adult patients with r···【more】
Recommended：533Release date: 2025-12-04
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 study showed that for patients with HER2-positive locally advanced or metastatic ···【more】
Recommended：428Release date: 2025-12-01
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrophy (SMA), announced today its welcome for the U.S. Food and Drug Administration ···【more】
Recommended：408Release date: 2025-11-27
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued favorable opinions, proposing an amendment to the mark···【more】
Recommended：689Release date: 2025-01-13
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced solid tumors, although further prospective research is still required. Historica···【more】
Recommended：592Release date: 2025-01-06
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administration (FDA) has given the green light to the first generic version of Victoza (···【more】
Recommended：660Release date: 2024-12-30
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
